Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Herceptin + docetaxel + pertuzumab versus Herceptin + docetaxel + placebo in previously untreated HER2-positive metastatic breast cancer
pertuzumab
WO20698 (CLEOPATRA)
NCT00567190
malignant neoplasm of breast
Phase 3
 
January 2014

Powered by ideaPoint, Inc.